217 related articles for article (PubMed ID: 33559190)
1. The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
Chen Z; Dong D; Zhu Y; Pang N; Ding J
FASEB J; 2021 Mar; 35(3):e21401. PubMed ID: 33559190
[TBL] [Abstract][Full Text] [Related]
2. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
3. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
[TBL] [Abstract][Full Text] [Related]
4. Activated Tim-3/Galectin-9 participated in the development of multiple myeloma by negatively regulating CD4 T cells.
Zhang R; Chen S; Luo T; Guo S; Qu J
Hematology; 2024 Dec; 29(1):2288481. PubMed ID: 38108336
[TBL] [Abstract][Full Text] [Related]
5. Expression of Tim-3/Galectin-9 pathway and CD8+T cells and related factors in patients with cystic echinococcosis.
Zhao H; Ma Y; Tian F; Li B; Xiao N; Mo X; Aibibula M; Min H; Cai X; Zhang T; Ma X
Exp Parasitol; 2023 Nov; 254():108623. PubMed ID: 37793539
[TBL] [Abstract][Full Text] [Related]
6. Elevated Galectin-9 Suppresses Th1 Effector Function and Induces Apoptosis of Activated CD4
Yang S; Wang J; Chen F; Liu G; Weng Z; Chen J
Inflammation; 2017 Jun; 40(3):1062-1071. PubMed ID: 28393295
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.
Nebbia G; Peppa D; Schurich A; Khanna P; Singh HD; Cheng Y; Rosenberg W; Dusheiko G; Gilson R; ChinAleong J; Kennedy P; Maini MK
PLoS One; 2012; 7(10):e47648. PubMed ID: 23112829
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.
Pang N; Tudahong S; Zhu Y; He J; Han C; Chen G; Wang W; Wang J; Ding J
Immun Inflamm Dis; 2024 Feb; 12(2):e1177. PubMed ID: 38353382
[TBL] [Abstract][Full Text] [Related]
9. [Significance of Tim-3 and Its Ligand Galectin-9 in Th1/Th2 Imbalance in Patients with Multiple Myeloma].
Zhang R; Chen S; Luo TT; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1764-1770. PubMed ID: 38071058
[TBL] [Abstract][Full Text] [Related]
10. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
11. Splenic CD4
Huang N; Zhou R; Chen H; Zhang S; Li J; Wei W; Sun J; Ren S; Li B; Deng H; Yang J; Ji F; Li Z
Int J Immunopathol Pharmacol; 2021; 35():20587384211061051. PubMed ID: 34930041
[No Abstract] [Full Text] [Related]
12. The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft.
Wang F; He W; Zhou H; Yuan J; Wu K; Xu L; Chen ZK
Cell Immunol; 2007; 250(1-2):68-74. PubMed ID: 18353298
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis.
Kang J; Wei ZF; Li MX; Wang JH
J Biosci; 2020; 45():. PubMed ID: 32345786
[TBL] [Abstract][Full Text] [Related]
14. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
Nagahara K; Arikawa T; Oomizu S; Kontani K; Nobumoto A; Tateno H; Watanabe K; Niki T; Katoh S; Miyake M; Nagahata S; Hirabayashi J; Kuchroo VK; Yamauchi A; Hirashima M
J Immunol; 2008 Dec; 181(11):7660-9. PubMed ID: 19017954
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy.
Meggyes M; Miko E; Polgar B; Bogar B; Farkas B; Illes Z; Szereday L
PLoS One; 2014; 9(3):e92371. PubMed ID: 24651720
[TBL] [Abstract][Full Text] [Related]
16. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.
Yasinska IM; Sakhnevych SS; Pavlova L; Teo Hansen Selnø A; Teuscher Abeleira AM; Benlaouer O; Gonçalves Silva I; Mosimann M; Varani L; Bardelli M; Hussain R; Siligardi G; Cholewa D; Berger SM; Gibbs BF; Ushkaryov YA; Fasler-Kan E; Klenova E; Sumbayev VV
Front Immunol; 2019; 10():1594. PubMed ID: 31354733
[TBL] [Abstract][Full Text] [Related]
17. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
18. Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.
Li S; Zhu Y; Wang S; Li Y; Pang N; An M; Zhang F; Ding J
Mol Biol Rep; 2022 Aug; 49(8):7497-7506. PubMed ID: 35715604
[TBL] [Abstract][Full Text] [Related]
19. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
[TBL] [Abstract][Full Text] [Related]
20. TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas.
Li Z; Liu X; Guo R; Wang P
Tumour Biol; 2017 May; 39(5):1010428317698352. PubMed ID: 28475007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
